Nobel Biocare Holding AG-Strategy, SWOT and Corporate Finance Report - Ken Research

Nobel Biocare Holding AG-Strategy, SWOT and Corporate Finance Report

Nobel Biocare Holding AG-Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360? view of the company.

Key Findings

Detailed information on Nobel Biocare Holding AG required for business and competitor intelligence needs

A study of the major internal and external factors affecting Nobel Biocare Holding AG in the form of a SWOT analysis

An in-depth view of the business model of Nobel Biocare Holding AG including a breakdown and examination of key business segments

Intelligence on Nobel Biocare Holding AG’s mergers and acquisitions (M&A), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors

News about Nobel Biocare Holding AG, such as business expansion, restructuring, and contract wins

Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons To Buy

Gain understanding of Nobel Biocare Holding AG and the factors that influence its strategies

Track strategic initiatives of the company and latest corporate news and actions

Assess Nobel Biocare Holding AG as a prospective partner, vendor or supplier

Support sales activities by understanding your customers’ businesses better

Stay up to date on Nobel Biocare Holding AG’s business structure, strategy and prospects

Key Highlights

Nobel Biocare Holding (Nobel Biocare or ‘the company’) is one of the leading providers of restorative and esthetic dental solutions. The company operates in Europe, Middle East and Africa (EMEA), North America, Asia/Pacific and Latin America. It is headquartered in Zurich, Switzerland, and employed 2,487 people as on December 31, 2013.

scroll to top